DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Ginni Filaments Limited — Outcome of Board Meeting

NSE 2 hrs ago·28 Jul 2026, 9:06 am

Ginnifilaments

Ginni Filaments Limited has informed stock exchanges that its board has approved the financial results for the period ending June 30, 2026. This filing is a routine corporate governance requirement, indicating that the company has completed its internal review and statutory audit processes for the specified quarter.

For investors, this announcement is primarily a procedural update. It confirms that the company is on track to disclose its financial performance, which will include key metrics like revenue and profit. While the specific numbers are not yet public, this development signals the upcoming release of the official quarterly earnings report.

Investors should wait for the detailed financial statements to be released. The market will focus on the company’s revenue growth, operating margins, and any commentary on future demand. Keeping an eye on the official filing will provide clarity on the company's current financial health and operational outlook.